Share on StockTwits

Analysts at Leerink Swann upped their price target on shares of Mallinckrodt PLC (NYSE:MNK) to $55.00 in a research report issued to clients and investors on Friday, Stock Ratings reports. Leerink Swann’s price objective would indicate a potential downside of 4.99% from the stock’s previous close.

Mallinckrodt PLC (NYSE:MNK) traded up 0.68% on Friday, hitting $57.89. The stock had a trading volume of 999,187 shares. Mallinckrodt PLC has a 1-year low of $41.00 and a 1-year high of $61.77. The stock’s 50-day moving average is $55.61 and its 200-day moving average is $48.10. The company has a market cap of $3.363 billion and a price-to-earnings ratio of 56.54.

Mallinckrodt PLC (NYSE:MNK) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.88 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.66 by $0.22. The company had revenue of $540.20 million for the quarter, compared to the consensus estimate of $539.24 million. Mallinckrodt PLC’s revenue was up 7.2% compared to the same quarter last year. On average, analysts predict that Mallinckrodt PLC will post $2.53 earnings per share for the current fiscal year.

In other Mallinckrodt PLC news, CEO Mark Trudeau sold 14,890 shares of Mallinckrodt PLC stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $56.12, for a total transaction of $835,626.80. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

A number of other analysts have also recently weighed in on MNK. Analysts at Jefferies Group raised their price target on shares of Mallinckrodt PLC from $60.00 to $66.00 in a research note to investors on Friday. Separately, analysts at UBS AG downgraded shares of Mallinckrodt PLC from a “neutral” rating to a “sell” rating in a research note to investors on Monday, January 27th. They now have a $43.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Morgan Stanley initiated coverage on shares of Mallinckrodt PLC in a research note to investors on Wednesday, January 8th. They set an “overweight” rating and a $60.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $50.36.

Mallinckrodt public limited company (NYSE:MNK) is a global specialty pharmaceuticals company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.